40 studies found for:    "Thyroid cancer anaplastic"
Show Display Options
Rank Status Study
21 Completed Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer
Conditions: Metastatic Differentiated Thyroid Cancer;   Metastatic Poorly Differentiated Thyroid Cancer;   Metastatic Anaplastic Thyroid Cancer;   Metastatic Medullary Thyroid Cancer
Intervention: Drug: sorafenib
22 Not yet recruiting A Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC)
Condition: Thyroid Cancer, Anaplastic
Intervention: Drug: Lenvatinib 24 mg
23 Recruiting Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer
Condition: Thyroid Gland Undifferentiated (Anaplastic) Carcinoma
Interventions: Radiation: Intensity-Modulated Radiation Therapy;   Drug: Paclitaxel;   Drug: Pazopanib Hydrochloride;   Other: Placebo
24 Completed Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer
Condition: Head and Neck Cancer
Interventions: Biological: filgrastim;   Drug: fluorouracil;   Drug: hydroxyurea;   Drug: paclitaxel;   Procedure: conventional surgery;   Radiation: radiation therapy
25 Unknown  Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer
Condition: Thyroid Cancer
Intervention: Drug: pemetrexed + paclitaxel
26 Active, not recruiting Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients
Condition: Thyroid Carcinoma
Intervention: Drug: Sorafenib (Nexavar,BAY43-9006)
27 Not yet recruiting Study for the Evaluation of Efficacy of Pembrolizumab (MK-3475) in Patients With Rare Tumors
Condition: Advanced Cancers
Interventions: Drug: Pembrolizumab;   Behavioral: Phone Call Follow-Up
28 Terminated Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.
Conditions: Melanoma;   Thyroid Cancer;   Colorectal Cancer;   Non-small Cell Lung Cancer;   Cholangiocarcinoma;   Histiocytosis;   Hairy Cell Leukemia
Intervention: Drug: PLX8394
29 Completed Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer
Condition: Head and Neck Cancer
Interventions: Drug: everolimus;   Other: laboratory biomarker analysis
30 Unknown  Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer
Condition: Head and Neck Cancer
Intervention: Drug: everolimus
31 Withdrawn S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer;   Head and Neck Cancer;   Lung Cancer;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: docetaxel;   Drug: vandetanib;   Genetic: proteomic profiling;   Other: laboratory biomarker analysis;   Other: pharmacological study
32 Completed Iodine I 131 in Treating Patients With Thyroid Cancer
Condition: Head and Neck Cancer
Interventions: Procedure: computed tomography;   Procedure: radionuclide imaging;   Procedure: single photon emission computed tomography;   Radiation: iodine I 131
33 Completed NGR-TNF in Treating Patients With Advanced Solid Tumors
Conditions: Colorectal Cancer;   Head and Neck Cancer;   Kidney Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Biological: CNGRC peptide-TNF alpha conjugate
34 Unknown  Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy
Condition: Head and Neck Cancer
Intervention: Drug: gefitinib
35 Completed Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases
Conditions: Colorectal Cancer;   Head and Neck Cancer;   Metastatic Cancer
Interventions: Drug: boronophenylalanine-fructose complex;   Drug: sodium borocaptate;   Procedure: conventional surgery
36 Completed Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
Conditions: Colorectal Cancer;   Endometrial Cancer;   Head and Neck Cancer;   Liver Cancer;   Lung Cancer;   Melanoma (Skin);   Pancreatic Cancer;   Testicular Germ Cell Tumor;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: aldesleukin;   Biological: ras peptide cancer vaccine;   Biological: sargramostim;   Drug: DetoxPC
37 Completed Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
Condition: Cancer
Interventions: Biological: trastuzumab;   Drug: tipifarnib
38 Completed SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck
Condition: Head and Neck Cancer
Interventions: Drug: paclitaxel;   Drug: semaxanib
39 Completed Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
Conditions: Adrenocortical Carcinoma;   Brain and Central Nervous System Tumors;   Head and Neck Cancer;   Liver Cancer;   Malignant Mesothelioma;   Pheochromocytoma;   Sarcoma
Interventions: Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: tamoxifen citrate;   Procedure: conventional surgery;   Radiation: radiation therapy
40 Recruiting A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting
Conditions: Differentiated Thyroid Cancer (DTC);   Poorly Differentiated Thyroid Cancer
Intervention: Drug: Cabozantinib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page   
Indicates status has not been verified in more than two years